quadrivalent influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes
split virion, inactivated) suspension for injection 0.5ml pre-filled syringes (sanofi - influenza virus split virion - suspension for injection
fluarix tetra suspension for injection in pre-filled syringe influenza vaccine (split virion, inactivated)
glaxosmithkline (ireland) limited - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238; a/darwin/9/2021 (h3n2)-like strain (a/darwin/6/2021, ivr-227); b/austria/1359417/2021 - like strain (b/austria/1359417/2021, bvr-26) [victoria lineage]; b/phuket/3073/2013 -like strain (b/phuket/3073/2013, wild type) - suspension for injection in pre-filled syringe - 15 international unit(s) - influenza vaccines; influenza, inactivated, split virus or surface antigen
fluarix 15mcg / 0.5ml suspension for injection im/sc
glaxosmithkline phils inc - influenza vaccine (split virion, inactivated) northern hemisphere 2013-2014 strain - suspension for injection im/sc - 15mcg / 0.5ml
influvac sub-unit tetra, suspension for injection in pre-filled syringe 15mcg/0.5ml
mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - influenza vaccine, split virion, inactivated - suspension for injection in pre-filled syringe - influenza vaccine (split virion, inactivated) 15 µg - vaccines
fluvax inactivated influenza vaccine (split virion) thiomersal free 0.5 ml injection syringe 2019
seqirus pty ltd - influenza virus haemagglutinin -
fluvax inactivated influenza vaccine (split virion) thiomersal free 0.5ml injection syringe with attached needle 2019
seqirus pty ltd - influenza virus haemagglutinin -
influvac suspension for injection (influenza vaccine, surface antigen, inactivated)
abbott biologicals b.v. - influenza vaccine (split virion, inactivated) 15 µg - suspension for injection in pre-filled syringe
fluarix tetra susp for inj in pre-filled syringe / influenza vaccine (split viron, inactivated)
glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - a, brisbane, h, ivr, kansas, nymc x, phuket, wild type, nymc bx - suspension for injection in pre-filled syringe - a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227 15 µg b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) 15 µg b/austria/1359417/2021 - like strain (b/austria/1359417/2021 bvr-26 15 µg a/victoria/4897/2022 (h1n1) pdm09 - like strain (a/victoria/4897/2022 ivr-238 15 µg - vaccines
fluarix tetra vaccine suspension for injection 0.5ml pre-filled syringes
glaxosmithkline uk ltd - influenza virus split virion - suspension for injection
fluarix tetra
glaxo smith kline (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - suspension for injection - b/phuket/3073/2013 (b/yamagata lineage)-like virus 30 mcg ha / 1 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 30 mcg ha / 1 ml; a/darwin/9/2021 (h3n2)-like virus 30 mcg ha / 1 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 30 mcg ha / 1 ml - influenza, inactivated, split virus or surface antigen - fluarix tetra is indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the two influenza a virus subtypes and the two influenza b virus types contained in the vaccine.